Chronos Archive seal

Review checklist: Rabindranath Tagore (HR-ET021)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the retention work-up, the PSA decision, catheter care and the infection treatment, the trials without catheter, finasteride, the surgical options for an 85 mL prostate in a frail man, the Beers review, and the recorded deviation.
provenance reviewnot_startedNobel Prize biography and citation, Wikipedia, the Visva-Bharati history page, a journal review of five memoirs by women who nursed him, and two news reports of a 2016 exhibition and a 2018 reconstruction logged. The 1937 and 1940 illnesses, his preference for traditional treatment, his fear of the operation, its date, and his death are D; the enlarged prostate, the nature of the operation, the cause of death, and prostate cancer are R and conflict. No statement, decision, or health fact is attributed to a relative, caregiver, or historical physician in the modern episode.
safe messaging reviewnot_startedHis death is recorded as a fact without detail. His reluctance about surgery and his trust in traditional medicine are recorded with respect, as documented. PHQ-2 is negative, so no safety assessment is required.

Judgment calls (dossier editorial resolutions)

  1. Index age and dates. The episode presents him at 79, before the operation of July 1941, as the assignment asked. The synthetic date of birth is May 7, 1946, so the whole-year shift is 85 years and 2026 maps to 1941. The index visit is February 17, 2026 (true frame February 17, 1941, after the documented Kalimpong illness of September 1940). The visits are March 3 (consultation), March 17 (sick visit), March 31, April 28, June 9 (annual wellness visit), and July 14, 2026 (true frame March 3, 17, and 31, April 28, June 9, and July 14, 1941). All precede the documented operation on July 30, 1941, and his death on August 7, 1941. He turns 80 on May 7, so the wellness visit is at 80. The visit spacing follows the AUA and CMID response visits: two weeks after drainage, a trial without catheter at six weeks, a decision visit four weeks later, and a second trial after about four months of finasteride. Past medical history includes only the late-1937 loss of consciousness and the September 1940 illness at Kalimpong; the operation, its complications, and his death stay in the claims and timeline and are omitted from intake documents.
  2. Presenting problem. The episode begins before the diagnosis. Urinary retention of unknown cause (R33.9) is the intake problem, resolved on March 3, 2026, when benign prostatic hyperplasia with lower urinary tract symptoms (N40.1) and chronic urinary retention (R33.8) are recorded. The catheter-associated infection (T83.511A) is recorded at the sick visit and resolved at the March 31 visit; mild frailty (R54) is recorded on March 31. Care-plan steps decided later carry `recorded_date`: finasteride and the trial plan (March 3), the surgical counseling (March 31), and his decision (April 28).
  3. Diagnostic and historical conflict. The 1937 and 1940 illnesses, the severe urinary infection at Kalimpong, his reliance on allopathic, homeopathic, and ayurvedic treatment, his reported refusal of surgery and his fear of complicated treatment, his anxiety before the operation, the operation at Jorasanko, and his death are D (some probable, from news reports of university reconstructions). The enlarged prostate stopping his urine flow is a retrospective medical reading (R, probable). The nature of the operation conflicts: a bypass to drain urine without operating on the prostate (Gulf News, from Rabindra Bharati University's reconstruction) or an operation that “was performed and it was successful” (Asia Times, from a urologist) (R, disputed). Septicaemia after the operation as the cause of death is R, possible. Prostate cancer, stated by a vice-chancellor in 2018 and not by the urologist, is R, disputed, and is not adopted: the modern episode makes no cancer diagnosis, its PSA results are within the age-specific range with a low PSA density, and no MRI or biopsy is done, in keeping with his stated wishes. The operation date conflicts slightly: the memoir review and the news reports give 30 July 1941, while Wikipedia says he dictated a poem on 30 July “a day before a scheduled operation”; 30 July is preferred.
  4. Not verified. Erysipelas or any other diagnosis for the 1937 illness was not found in a source I could read and is not used. Krishna Dutta and Andrew Robinson's biography could not be read or found quoted on these points by a reliable source and is not cited. The BJU International blog post on his last days (by the urologist quoted in Asia Times) returned HTTP 404. The excerpt from Swati Ganguly's history of Visva-Bharati could not be fetched. No peer-reviewed medical-history article on his final illness was found in PubMed. The sources name the operating surgeon inconsistently; no surgeon is named in this record.
  5. His values and traditional medicine. His documented reluctance about surgery and his trust in ayurvedic treatment are recorded with respect, as documented, and the modern episode honors them: his traditional physician's herbal preparation is continued after a pharmacist's review, with advice to buy from a tested supplier (JAMA 2008), and a blood lead level is offered and declined; no product or practitioner is named, and no judgment on ayurveda is made. His decision to defer surgery after a failed trial is recorded as an informed choice with clear criteria to reconsider. His words in the modern episode (“patient, but tired of my own body”, his fear of being “put to sleep and cut”) are synthetic statements of the modern patient, not quotations from his writings; they echo, and are linked to, the documented report that he was more afraid of complicated treatment than of death. The modern episode deliberately avoids an operation and ends with a successful second trial without catheter, so it does not re-enact or comment on his real operation.
  6. Real people. His father appears only in the documented birth claim, and his daughter Renuka only in the family history (tuberculosis; cause of death not recorded in the cited source). Bidhan Chandra Roy, Nilratan Sarkar, and the women who nursed him appear only in documented claims. In the modern episode his family and helpers are unnamed; one unnamed helper notices that he was slow to answer in the night, and no relative or helper is given a decision or a health fact. His health care agent is not named.
  7. Name and aliases. “Tagore” is the anglicised form of the family name Thakur. The display name “Rabindranath Tagore” splits normally into a given name and a family name, so `name_parts` is not needed. The aliases “Rabindranath Thakur” and “Gurudev” appear in no other record. Wikipedia transliterates the sobriquet as “Gurudeb”; “Gurudev” is the common English spelling and the title of a memoir by one of his nurses.
  8. Sick visit. The sick visit (March 17, 2026; true frame March 17, 1941) is a febrile catheter-associated urinary tract infection without sepsis, four weeks into catheter drainage, treated at home with ceftriaxone and cefpodoxime for 7 days after a catheter change and cultures. It was chosen because it follows from the catheter and teaches catheter-associated infection management, delirium screening (4AT 0), and Beers-guided antibiotic choice (no fluoroquinolone). It echoes the documented urinary infection of September 1940 and the reported post-operative septicaemia, which are linked as claims, but it asserts neither.
  9. Wellness visit. At 80 the preventive visit is `annual_wellness_subsequent` (his previous wellness visit was with a former physician). It adds RSV, PCV20, and recombinant zoster vaccines, a falls referral to physiotherapy, and advance care planning with a health care agent named but not recorded by name. Prostate cancer screening is not indicated at 80; PSA is followed only as part of finasteride treatment.
  10. Focused visits. The four chronic-care follow-ups (two weeks, six weeks, ten weeks, and five months) are documented as focused visits on the CMID benign prostatic hyperplasia monograph, the AUA guideline (2021, amended 2023), the AUA chronic retention white paper, IDSA 2009, and the AGS Beers Criteria 2023: the IPSS (not scored while catheterized; 26 at intake and 13 after the second trial), post-void residual (640, 420, and 150 mL), creatinine and electrolytes, the ultrasound, PSA (4.9 ng/mL at baseline; 2.6 ng/mL after four and a half months of finasteride, doubled to 5.2), digital rectal examination, catheter care, tamsulosin and finasteride effects, culture results, the geriatric assessment (Clinical Frailty Scale 5, Timed Up and Go 15 seconds, Mini-Cog 4), the medication and herbal review, and the surgical decision. One protocol deviation is recorded as `deferred`, with its outcome and corrective action, and no result was invented: orthostatic blood pressure was not measured two to four weeks after starting tamsulosin and was first measured at six weeks, with no orthostatic hypotension and no falls. The Clinical Frailty Scale, Timed Up and Go, 4AT, and culture results are recorded in the note text; the IPSS uses the LOINC AUA symptom index score (80891-5) and its quality-of-life item (81090-3), because no separate IPSS total-score code was found.
  11. Consultation. The urology referral and consultation (Helena Marsh-Okoro, MD, a fictional consultant, on the day of the two-week visit) are S. The consultant finds low-risk chronic retention from benign prostatic obstruction and recommends what the record then shows: finasteride (started that day), tamsulosin with a trial without catheter at about six weeks (done, and failed), the indwelling catheter with intermittent self-catheterization offered (he preferred the indwelling catheter), no MRI or biopsy, HoLEP as the preferred operation for refractory retention with prostatic artery embolization as the less invasive option (both offered after the failed trial), a geriatric assessment before any decision (done), and a long-term catheter or a second trial after three to six months of finasteride if he declined a procedure (he chose the second trial, which succeeded).
  12. Primary clinician. Arvind Sengupta, MD, is cast as a general internist with geriatric training.
  13. Tagore died in 1941, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required. Claims about his illnesses, operation, and death are marked sensitive.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-03-31
Progress note 04 (C-CDA)
Orthostatic blood pressure 2 to 4 weeks after starting tamsulosinOnce, 2 to 4 weeks after starting an alpha-blocker in an older adultMissed: it was not measured at the two-week visit. Done today, six weeks after starting: 128/72 seated and 122/70 mmHg standing, no orthostatic hypotension; no falls in the interval, so no harm. Corrective action: orthostatic readings added to the alpha-blocker follow-up template

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-06-09
Progress note 06 (C-CDA)
PreventionFalls preventionReferredTimed Up and Go 14 seconds; referred to physiotherapy for strength and balance exercises

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0011Doctors reviewing his records for a 2016 exhibition said he had an enlarged prostate that was stopping his urine flow.probable
CLM-0012Accounts of the operation differ: one says the doctors could not operate on the enlarged prostate and instead performed a bypass to drain the accumulated urine and relieve pain; another says the operation was performed and was successful.disputed
CLM-0013Present-day doctors believe that infection after the operation led to septicaemia and his death.possible
CLM-0014A university vice-chancellor said in 2018 that he was suffering from cancer in his prostate; other accounts describe only an enlarged prostate.disputed

Sensitive claims

ClaimGradeStatement
CLM-0005DHis last five years were marked by chronic pain and two long periods of illness: in late 1937 he lost consciousness and remained comatose and near death for a time, and in late 1940 a similar spell followed, from which he never recovered.
CLM-0006DOn 15 September 1940, while visiting Kalimpong, he fell seriously ill with severe pain in his lower abdomen; doctors diagnosed a severe urinary tract infection, and he was brought back, unconscious, to Calcutta.
CLM-0007DIn the last two years of his life illness confined him to the house, with swollen feet, numbness of the fingers, and frequent fevers; women of his family and household nursed him at home.
CLM-0008DHe sought cure in allopathy, homeopathy, and ayurvedic medicine; physicians including Bidhan Chandra Roy and Nilratan Sarkar supervised his treatment; he is reported to have refused surgery despite repeated insistence from his doctors, to have sought a herbal cure, and to have said that he was more afraid of complicated medical treatment than of death.
CLM-0009DHe was very anxious about the operation and asked several times whether it would hurt; a few days before it he asked for a prayer-poem asking not for rescue from danger but for courage in it.
CLM-0010DHe was operated on at Jorasanko, on a veranda outside his room made into an operating theatre, on 30 July 1941; one reference work instead says he dictated a poem on 30 July, a day before a scheduled operation.
CLM-0011RDoctors reviewing his records for a 2016 exhibition said he had an enlarged prostate that was stopping his urine flow.
CLM-0012RAccounts of the operation differ: one says the doctors could not operate on the enlarged prostate and instead performed a bypass to drain the accumulated urine and relieve pain; another says the operation was performed and was successful.
CLM-0013RPresent-day doctors believe that infection after the operation led to septicaemia and his death.
CLM-0014RA university vice-chancellor said in 2018 that he was suffering from cancer in his prostate; other accounts describe only an enlarged prostate.
CLM-0015DHe died on 7 August 1941, aged 80, at the Jorasanko house, after a prolonged period of suffering.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-02-17Post-void residual (bladder scan)640 mL (high)High
2026-02-17BUN27 mg/dL (high)High
2026-02-17Creatinine1.42 mg/dL (high)High
2026-02-17eGFR50 mL/min/1.73 m² (low)Low
2026-03-03Prostate volume (ultrasound)85 mL (high)High
2026-03-17White blood cells13.8 10*3/uL (high)High
2026-03-17BUN25 mg/dL (high)High
2026-03-17eGFR55 mL/min/1.73 m² (low)Low
2026-03-17Glucose112 mg/dL (high)High
2026-03-17Urine white cells60 /[HPF] (high)High
2026-03-31Post-void residual (bladder scan)420 mL (high)High
2026-07-14Post-void residual (bladder scan)150 mL (high)High